Rebuilding After Sa...
Health Care: Drugs
International Stem Cell (ISCO: OTC)
$0.30 0.00 | -1.67%
05/22/13 - 02:58 PM ET
202.97K / 185.60K
Vol / Avg. Vol:0.30 / 0.30
Open / Prev. Close:0.25 - 0.30
Today's Range:0.16 - 0.45
52 Wk Range:-20.00%
Performance YTD:TheStreet Rating:
Portfolios with ISCO
- Portfolio NameUser Type
- UserMark
- UserLarry Level III
- Usergatorfao Portfolio 1
Latest ISCO Headlines from TheStreet
Press Releases for ISCO
- SeeThruEquity Announces Company Lineup For Fall 2012 Smallcap And Microcap Investor Conference On October 2 And 3, 2012 - Business Wire 09.24.12 | 11:09 am
- International Stem Cell Corporation Scientists Create New Protein-Based Stem Cell Technology - Business Wire 06.14.12 | 08:06 am
- International Stem Cell Corporation Announces Marketing Plans For Its Wholly Owned Subsidiary Lifeline Skin Care - Business Wire 06.12.12 | 08:06 am
- International Stem Cell Corporation Scientists To Present Pre-Clinical Research Results At American Society Of Gene And Cell Therapy 15th Annual Meeting - Business Wire 05.15.12 | 08:05 am
- International Stem Cell Corporation Provides Update On Lifeline Skin Care Business Activities - Business Wire 04.03.12 | 08:04 am
- International Stem Cell Corporation Announces 2011 Financial Results - Business Wire 03.20.12 | 08:03 am
- International Stem Cell Corporation Completes $5 Million Financing And Elects Jim Berglund To The Board Of Directors - Business Wire 03.12.12 | 08:03 am
- International Stem Cell Corporation To Present At The Roth Conference On March 14 - Business Wire 03.07.12 | 08:03 am
- International Stem Cell Corporation To Present At The 4th Annual LD MICRO Growth Conference On December 8 - Business Wire 12.01.11 | 08:12 am
- International Stem Cell Corporation To Present Immune Matching Research Advances At Cell Science And Stem Cell Research 2011 Conference - Business Wire 11.29.11 | 08:11 am
Partner Headlines for ISCO
- Analyst Interview - International Stem Cell - Analyst Blog - Zacks 07.27.11 | 06:07 am
- Stem Cell Confusion Creates Opportunity - Analyst Blog - Zacks 08.25.10 | 09:08 am
